Daiwa Securities Group Inc. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1
-50.0%
5010.0%0.00%
Q2 2023$2
-33.3%
5010.0%0.00%
Q1 2023$30.0%5010.0%0.00%
Q4 2022$3
-99.8%
501
+59.6%
0.00%
Q3 2022$2,000
+100.0%
3140.0%0.00%
Q2 2022$1,000
-50.0%
3140.0%0.00%
Q1 2022$2,000
-33.3%
3140.0%0.00%
Q4 2021$3,000
+50.0%
3140.0%0.00%
Q3 2021$2,000
-50.0%
314
+82.6%
0.00%
Q2 2021$4,0000.0%1720.0%0.00%
Q1 2021$4,0000.0%1720.0%0.00%
Q4 2020$4,000
-69.2%
172
-61.3%
0.00%
Q3 2020$13,000
+550.0%
4450.0%0.00%
Q2 2020$2,0000.0%4450.0%0.00%
Q1 2020$2,0000.0%4450.0%0.00%
Q4 2019$2,0000.0%4450.0%0.00%
Q3 2019$2,000
+100.0%
445
+98.7%
0.00%
Q2 2019$1,000
-50.0%
2240.0%0.00%
Q1 2019$2,000
+100.0%
2240.0%0.00%
Q4 2018$1,000
-50.0%
2240.0%0.00%
Q3 2018$2,0000.0%2240.0%0.00%
Q2 2018$2,0000.0%2240.0%0.00%
Q1 2018$2,0002240.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$148,411,0006.25%
Eversept Partners, LP 1,935,825$12,427,9971.08%
Kynam Capital Management, LP 772,820$4,962,0001.05%
SILVERARC CAPITAL MANAGEMENT, LLC 366,493$2,353,0000.80%
Lion Point Capital, LP 626,803$3,228,0000.71%
FEDERATED HERMES, INC. 18,499,136$118,765,0000.35%
Knott David M Jr 110,000$706,0000.30%
Atom Investors LP 108,820$699,0000.25%
Ikarian Capital, LLC 131,310$843,0000.17%
HARVARD MANAGEMENT CO INC 131,847$846,0000.10%
View complete list of SERES THERAPEUTICS INC shareholders